Barclays raises Iovance Biotherapeutics target price to $18 from $15
IOVA•Barclays raised its target price for Iovance Biotherapeutics to $18 from $15.
Related News
Truist Securities raises Meta target price to $1,000 from $763
META•
Clorox target price cut to $80 from $85
CLX•
United Therapeutics presents preliminary PHINDER study data to develop PH-ILD screening tool at CHEST 2026
UTHR•
SS&C GlobeOp Capital Movement Index shows hedge fund net flows fall 0.16% in October
SSNC•
IQVIA expands partnership with Veeva, adopts its clinical operations applications across trials
VEEV•